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Commentary
I n a linked research paper, Williamson and colleagues 1 evaluated the effect of auto inflation, by nostril, of a purposedesigned rubber balloon in 320 children aged 4-11 years with glue ear. Glue ear (also known as secre tory otitis media or otitis media with effusion) affects as many as 80% of children, with peaks in incidence at two and five years of age. 2 The consequent deafness may interfere with lan guage acquisition, behaviour and education, which worries parents of affected children. Effective treatment options are few.
One of the main findings of the linked study is that glue ear had resolved -by objective measurement using tympanometry -at three months in a greater proportion of children in the intervention group than in the control group. The number needed to treat was only nine. The objective outcome measure was important in this trial because participants could not be masked to allocation. The intentiontotreat analysis also showed improvements in the quality of life of children in the intervention group at three months. Possible adverse effects were common colds and earaches, with a slightly higher num ber of these among the children who used auto inflation. Child and parent acceptance of the intervention was good, with a compliance rate of 80% at three months.
At last, there is something effective to offer children with glue ear other than surgery. Surgi cal insertion of grommet ventilation tubes through the tympanic membrane is immediately effective, as shown by a Cochrane review involving 1728 participants in 10 trials. 3 How ever, it has no benefit beyond six months, at which time the deafness of most children in the control groups resolves naturally, and no effect has been shown on the important outcomes of speech and language development. This important trial by Williamson and col leagues effectively addresses the lack of medical treatments for glue ear available to primary care clinicians. Clinicians are often tempted to use antibiotics in children with glue ear in the futile hope that they might help. A Cochrane system atic review involving 3027 children in 23 studies found that antibiotics are not effective. 4 Further more, unnecessary antibiotic use exposes pa tients to potential adverse effects 5 and contrib utes to the development of antibiotic resistance. 6 Use of autoinflation as a firstline treatment for glue ear may reduce the number of children who need to undergo surgery for grommet tube place ment. Some cases will have resolved before sur gery (an estimated 1 in 10 if surgery is delayed by three months 3 ), and some parents who are con cerned about the risks of surgery, hospital admis sion and anesthetic may elect to persevere with autoinflation beyond three months.
Autoinflation is one of a number of effec tive nondrug interventions typically underrep resented in research and clinical practice. Get ting the message to clinicians about effective nondrug treatments is much harder than it is for drug treatments. Furthermore, prescribing nondrug interventions requires clinicians to know the details of the intervention (as op posed to being able to look up details on pre scribing information in a pharmacopeia), and many nondrug trials do not describe the inter ventions in enough detail for them to be used in practice. 7 In the case of the intervention evaluated in the current trial, once the physi cian knows about autoinflation and its effec tiveness, the device needs to be available for purchase or dispensing, and the physician must know how to use it and be able to instruct the patient and parents in how and when to use it (in the current trial, the prescription was three times per day for three months).
Williamson and colleagues mostly follow the TIDieR (Template for Intervention Description and Replication) guidelines for intervention reporting 8 and therefore provide most of the
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detail that a physician will need to prescribe the intervention. A physician who wishes to pre scribe autoinflation might be wise to obtain a balloon device to use for demonstration and might choose to teach a practice nurse to dem onstrate the intervention to the parent and child.
To overcome the lack of a pharmacopeia equivalent for effective nondrug interventions, the Royal Australian College of General Practi tioners has recently launched the freely available Handbook of NonDrug Interventions (HANDI) (www.racgp.org.au/handi). Autoinflation is an intervention that will soon be included in HANDI. Inclusion in this resource will mean that physicians will be able to access details about this nondrug intervention in future, long after reading the article by Williamson and colleagues.
